PhD student position aimed at peptide specific targeting of vascular disease lesions
The Translational Genomics Lab within AstraZeneca Discovery Sciences, IMED Biotech Unit, in Gothenburg, Sweden is a state-of-the-art molecular biology, cell biology and animal facility, driving cell and animal model work on the AstraZeneca Gothenburg site. Our labs are fully equipped to support molecular biology, in vitro and in vivo activities. In addition, through sister teams in the department, we have access to key equipment and skilled personnel including protein science, Next Generation Sequencing and assay development.
For the EU-MSCA-ETN project V.A. Cure, the lab invites applications for an Early Stage Researcher/PhD student position entitled:
Peptides for specific targeting of vascular lesions in venous malformation (VM), lymphatic malformation (LM) and arteriovenous malformation (AVM) (ESR3)
You will be part of a team of 14 ESRs working on the V.A. Cure project, which aims to uncover core mechanisms of initiation and maintenance of Vascular Anomalies with the final goal to establish novel therapeutic strategies. The project is funded in the frame of the EU MSCA-ITN programme.
You will work on a research project with the following objectives:
You will enrol in a PhD programme at Karolinska Institute.
We are looking for a motivated student with a strong commitment to basic and/or translational research, who:
The successful candidate will receive an attractive salary in accordance with MSCA regulations for Early Stage Researchers. The period of employment is 3 years. Starting date: June – October 2019.
How to apply
– Make sure you meet the qualifying requirements.
– Submit your application to: email@example.com. Please send one pdf file containing:
Deadline for submitting applications: 22 May 2019
Please visit www.vacure.eu for more information on the project, the recruitment and selection criteria. Specific questions about the position can be addressed to firstname.lastname@example.org by e-mail.